/PRNewswire/ Dragonfly Therapeutics, Inc. ("Dragonfly"), today announced that the first patient has been dosed in a clinical trial being conducted by Merck,.
Biktarvy Sales Increased 28% Year-Over-Year to $2.6 billionOncology Sales Increased 71% Year-Over-Year to $527 millionFOSTER CITY, Calif. (BUSINESS WIRE) #Earnings Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the second quarter of 2022.“This was a very strong quarter for Gile.
FOSTER CITY (dpa-AFX) - Gilead Sciences Inc. (GILD) reported that its second quarter net income attributable to the company declined to $1.14 billion or $0.91 per share from $1.52 billion or $1.21
Gilead Sciences Posts Slightly Higher 2Q Sales morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.